Retatrutide's 6-day half-life means it takes 4-5 weeks to reach steady-state levels at each dose, which is why the standard protocol uses gradual 4-week escalation intervals
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist Tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Experimental data suggest that GLUT1-mediated glucose transport may have differential effects in CD4 + and CD8 + T cells
In a 48-week, placebo-controlled phase-2 trial (338 participants) reported by Lilly, the highest dose achieved a mean weight reduction of 24.2% (about 57.8 lb) at the end of treatment
While eating too much fiber can lead to constipation in rare cases, that's much less of an issue than getting too little, says Saidman
At what stage were you diagnosed with Hashimotos